• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏菌素与美罗培南及万古霉素联合使用对具有多种碳青霉烯耐药机制的肠杆菌科细菌的体外协同作用及抗生素后效应

In vitro synergy and postantibiotic effect of colistin combinations with meropenem and vancomycin against Enterobacteriaceae with multiple carbapenem resistance mechanisms.

作者信息

Bedenić Branka, Car Haris, Slačanac Domagoj, Sviben Mario, Čačić Marko, Lukić-Grlić Amarela, Benčić Ana, Šijak Dorotea, Tripković Marko, Beader Nataša

机构信息

School of Medicine, University of Zagreb, Zagreb, Croatia; Department of Clinical and Molecular Microbiology, University Hospital Center Zagreb, Zagreb, Croatia.

Secondary Medical School, Zagreb, Croatia.

出版信息

J Infect Chemother. 2018 Dec;24(12):1016-1019. doi: 10.1016/j.jiac.2018.06.001. Epub 2018 Jul 11.

DOI:10.1016/j.jiac.2018.06.001
PMID:30006247
Abstract

AIM

The aim of the study was to determine in vitro synergy and postantibiotic effect of colistin alone and combined with meropenem or vancomycin against Enterobacteriaceae producing multiple carbapenemases; combinations of two metallo-β-lactamases (MBL) or MBL with OXA-48. Colistin-resistant strain positive for OXA-48 was also included in the study.

METHODS

The antibiotic susceptibility was tested by broth microdilution method. Synergy was tested by chequerboard, time-kill and 2-well method. PAE was determined by viable counting.

RESULTS

The chequerboard analysis revealed synergy for colistin combination with meropenem in all isolates with FICI values ranging from 0.12 to 0.24. FICI values for combinations with vancomycin were below 0.5 indicating synergy in two out of four isolates. K. pneumoniae 609815 positive for OXA-48 and colistin resistant showed the most pronounced and consistent synergy effect with meropenem in both chequerboard and time-kill method. Synergy effect in time-kill curves, was observed for K pneumoniae 145846 with two MBLs and colistin resistant K. pneumoniae 609815 positive for OXA-48, with both combinations including meropenem and vancomycin. Colistin alone exhibited short postantibiotic effect (PAE) against all tested isolates. Meropenem markedly prolonged the PAE in two isolates in contrast to vancomycin which did not demonstrate significant effect on the duration of PAE.

CONCLUSIONS

The synergy effect and the duration of PAE was strain and antibiotic dependent but not related to the resistance gene content.

摘要

目的

本研究旨在确定单独使用黏菌素以及黏菌素与美罗培南或万古霉素联合使用对产多种碳青霉烯酶的肠杆菌科细菌的体外协同作用和抗生素后效应;两种金属β-内酰胺酶(MBL)或MBL与OXA-48的组合。对OXA-48呈阳性的耐黏菌素菌株也纳入了研究。

方法

采用肉汤微量稀释法检测抗生素敏感性。通过棋盘法、时间杀菌法和双孔法检测协同作用。通过活菌计数法测定抗生素后效应。

结果

棋盘分析显示,黏菌素与美罗培南联合使用对所有分离株均有协同作用,FICI值范围为0.12至0.24。与万古霉素联合使用的FICI值低于0.5,表明在四分之二的分离株中有协同作用。对OXA-48呈阳性且耐黏菌素的肺炎克雷伯菌609815在棋盘法和时间杀菌法中与美罗培南均表现出最显著和一致的协同效应。在时间杀菌曲线中,观察到携带两种MBL的肺炎克雷伯菌145846以及对OXA-48呈阳性的耐黏菌素肺炎克雷伯菌609815在美罗培南和万古霉素两种组合中均有协同效应。单独使用黏菌素对所有测试分离株的抗生素后效应(PAE)较短。与万古霉素相比,美罗培南显著延长了两株分离株的PAE,而万古霉素对PAE持续时间未显示出显著影响。

结论

协同效应和PAE持续时间因菌株和抗生素而异,但与耐药基因含量无关。

相似文献

1
In vitro synergy and postantibiotic effect of colistin combinations with meropenem and vancomycin against Enterobacteriaceae with multiple carbapenem resistance mechanisms.黏菌素与美罗培南及万古霉素联合使用对具有多种碳青霉烯耐药机制的肠杆菌科细菌的体外协同作用及抗生素后效应
J Infect Chemother. 2018 Dec;24(12):1016-1019. doi: 10.1016/j.jiac.2018.06.001. Epub 2018 Jul 11.
2
Postantibiotic effect of colistin alone and combined with vancomycin or meropenem against Acinetobacter spp. with well defined resistance mechanisms.黏菌素单独及联合万古霉素或美罗培南对具有明确耐药机制的不动杆菌属的抗生素后效应
J Chemother. 2016 Oct;28(5):375-82. doi: 10.1179/1973947815Y.0000000062. Epub 2016 Jul 22.
3
In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.体外研究新型氨基糖苷类药物普拉佐米星单独及与黏菌素、美罗培南、磷霉素或替加环素联合对产碳青霉烯酶肠杆菌科菌株的活性。
Int J Antimicrob Agents. 2015 Dec;46(6):616-21. doi: 10.1016/j.ijantimicag.2015.07.021. Epub 2015 Sep 9.
4
Triple combination of meropenem, colistin and tigecycline was bactericidal in a dynamic model despite mere additive interactions in chequerboard assays against carbapenemase-producing Klebsiella pneumoniae isolates.美罗培南、黏菌素和替加环素三联组合在针对产碳青霉烯酶肺炎克雷伯菌分离株的棋盘微量稀释法中表现出单纯相加作用,但在动态模型中仍具有杀菌作用。
J Antimicrob Chemother. 2019 Feb 1;74(2):387-394. doi: 10.1093/jac/dky422.
5
Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.通过体外时间杀菌实验评估用于产VIM和NDM的肺炎克雷伯菌的双联和三联抗生素组合。
Antimicrob Agents Chemother. 2014;58(3):1757-62. doi: 10.1128/AAC.00741-13. Epub 2014 Jan 6.
6
In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.体外评估不同抗菌药物组合对产碳青霉烯酶肺炎克雷伯菌的抗菌活性:双碳青霉烯方案的活性与美罗培南 MIC 值相关。
J Antimicrob Chemother. 2017 Jul 1;72(7):1981-1984. doi: 10.1093/jac/dkx084.
7
Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.替加环素单独及联合黏菌素和美罗培南对产碳青霉烯酶肠杆菌科细菌(KPC)菌株的时间杀菌试验研究。
Int J Antimicrob Agents. 2011 Mar;37(3):244-7. doi: 10.1016/j.ijantimicag.2010.10.031. Epub 2011 Jan 13.
8
In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains.体外评估双重碳青霉烯类和黏菌素组合对产 OXA-48、NDM 碳青霉烯酶的黏菌素耐药肺炎克雷伯菌的作用。
Antimicrob Resist Infect Control. 2020 May 19;9(1):70. doi: 10.1186/s13756-020-00727-4.
9
In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48-positive Klebsiella pneumoniae strains.体外研究磷霉素联合亚胺培南、美罗培南、黏菌素和替加环素对产 OXA-48 阳性肺炎克雷伯菌的活性。
Diagn Microbiol Infect Dis. 2013 Jul;76(3):335-8. doi: 10.1016/j.diagmicrobio.2013.04.004. Epub 2013 May 29.
10
Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance.舒巴坦、美罗培南和黏菌素对耐碳青霉烯类肺炎克雷伯菌和鲍曼不动杆菌分离株的协同作用测定及其与耐药分子机制的相关性
J Chemother. 2016 Aug;28(4):297-303. doi: 10.1080/1120009X.2016.1143261.

引用本文的文献

1
Divergence and Convergence of Cerebral Ischemia Pathways Profile Deciphers Differential Pure Additive and Synergistic Mechanisms.脑缺血通路图谱的发散与汇聚解析了不同的纯加性和协同机制。
Front Pharmacol. 2020 Feb 25;11:80. doi: 10.3389/fphar.2020.00080. eCollection 2020.
2
XDR- isolates harboring : and evaluation using a murine thigh-infection model.携带超广谱耐药菌的分离株:以及使用小鼠大腿感染模型进行的评估。
Exp Biol Med (Maywood). 2019 Dec;244(18):1658-1664. doi: 10.1177/1535370219886826. Epub 2019 Oct 31.
3
Characterization of the anti-Staphylococcus aureus fraction from Penthorum chinense Pursh stems.
从贯叶连翘茎中分离抗金黄色葡萄球菌的部分的特性。
BMC Complement Altern Med. 2019 Aug 17;19(1):219. doi: 10.1186/s12906-019-2632-3.